Loading clinical trials...
Loading clinical trials...
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification
Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO classification, based on cIMPACT-NOW recommendations, results in more homogeneous patient groups than the old 2016 classification. Furthermore, it will help derive provisional guidelines on how patients with these newly defined tumour entities are best treated. These recommendations will be based on the experience of EORTC investigators with chosen treatments and their experience as reported in this data collection report.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Innsbruck Universitaetsklinik
Innsbruck, Austria
Universitaetsklinikum Wien - AKH unikliniken
Vienna, Austria
Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
Institut Jules Bordet
Anderlecht, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
C.H.U. Sart-Tilman
Liège, Belgium
AZ Delta - Campus Rumbeke
Roeselare, Belgium
CHU Lyon - Hopital neurologique Pierre Wertheimer
Lyon, France
Hopital de La Timone
Marseille, France
Hopital la Pitie-Salpetriere
Paris, France
Start Date
March 21, 2023
Primary Completion Date
December 30, 2027
Completion Date
July 29, 2038
Last Updated
December 17, 2025
1,650
ESTIMATED participants
Observational
OTHER
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
NCT05839379
NCT06860594
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions